Sickle Cell's Cure: CRISPR

Sickle cell disease (SCD) is a devastating medical condition causing pain, fatigue, and early mortality. Join host, Geoff Wall, as he evaluates a new gene therapy via CRISPR that may cure SCD. The GameChangerCRISPR is a new method to develop targeted gene editing treatments. Lovo-cel is the first FDA-approved therapy and may treat sickle cell disease (SCD) - for only $2 million. HostGeoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint Health ReferenceFDA Approval. https://www.fda.gov/vaccines-blood-biologics/lyfgenia. Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Discuss what CRISPR is and how it can be used to treat diseases 2. Describe the use of lovotibeglogene autotemcel (lovo-cel) for sickle cell disease and its safety and efficacy data 0.05 CEU/0.5 HrUAN: 0107-0000-24-031-H01-PInitial release date: 1/8/2024Expiration date: 1/8/2025Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram